Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,129,058
-
Total 13F shares
-
564,017
-
Share change
-
-707,936
-
Total reported value
-
$307,124
-
Price per share
-
$0.54
-
Number of holders
-
6
-
Value change
-
-$619,182
-
Number of buys
-
3
-
Number of sells
-
5
Institutional Holders of AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) as of Q4 2019
As of 31 Dec 2019 AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) had 6 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 564,017 shares of stock of the company.
Largest 6 holders included SABBY MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., DEUTSCHE BANK AG\, BANK OF AMERICA CORP /DE/, and American Portfolios Advisors.
This table shows 6 institutional shareholders of the security as of 31 Dec 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.